Pebblebrook's Q1 Earnings Date Is Routine. The Numbers Behind It Aren't.

Pebblebrook's Q4 2025 Adjusted FFO came in at $0.27 per diluted share, beating consensus by 25.81%. Revenue missed by 6.35% at $320.96 million. That divergence is the whole story. A REIT that's shrinking its top line and growing its bottom line is telling you exactly where management's attention is... and it's not on revenue growth. It's on cost structure, capital discipline, and debt reduction.

Let's decompose the Q4 numbers. Same-Property Hotel EBITDA rose 3.9% to $64.6 million on RevPAR growth of 2.9%. Out-of-room revenue grew 5.5%. The EBITDA beat the company's own midpoint by $2.2 million. That's flow-through discipline, not revenue expansion. Two dispositions generated $116.3 million in proceeds, $100 million of which went straight to debt paydown. They also closed a $450 million unsecured term loan maturing in 2031, replacing a $360 million facility due in 2027. Maturity extension plus deleveraging. The capital structure is being rebuilt while no one's watching.

The full-year 2025 net loss of $62.2 million includes $48.9 million in impairment charges from those dispositions. Strip the impairments and the operating loss narrows to $13.3 million. That's a REIT with 44 hotels and roughly 11,000 keys approaching breakeven on a GAAP basis while carrying $525 million in completed redevelopment capital. The 2026 outlook projects net income between negative $10.4 million and positive $3.6 million. The midpoint is essentially zero... which means 2026 is the year the redevelopment program either proves its thesis or doesn't. Same-Property RevPAR guidance of 2.25% to 4.25% growth and Adjusted FFO of $1.50 to $1.62 per share implies the company is pricing in modest recovery without heroic assumptions.

Here's what the earnings announcement doesn't surface. PEB closed Q4 at roughly $12.24 after a 7.15% post-earnings pop. Full-year 2026 FFO guidance midpoint of $1.56 puts the stock at approximately an 8x multiple. For a portfolio concentrated in urban and resort lifestyle assets with a freshly completed $525 million redevelopment cycle, that's cheap... unless you believe urban full-service is permanently impaired. The Q1 2026 outlook of $0.19 to $0.23 Adjusted FFO per share implies continued seasonality pressure, but the projected Q1 RevPAR growth of 7.5% to 9.0% suggests real momentum in markets like San Francisco that drove Q4 outperformance. The Palogic Value Fund withdrawing its activist campaign in February tells you something too. Either they got what they wanted behind closed doors, or they looked at the same math I just walked through and decided the thesis was already playing out.

The Q1 call on April 29 will matter for one reason. Capital allocation. With the redevelopment program largely complete, Pebblebrook's 2026 CapEx drops to normalized levels. That creates discretionary free cash flow that either goes to debt reduction, share repurchases at an 8x FFO multiple, or opportunistic acquisitions. The answer to that question reprices the stock. Everything else is noise.